Health China
Eighth International Congress on the Future of Breast Cancer
Grand Wailea Resort
3850 Wailea Alanui
Wailea, HI 96753
Eighth International Congress on the Future of Breast Cancer
Physicians' Education Resource

Schedule of Presentations:

Wednesday, July 22, 2009
06:30:00 Registration
07:00:00 Welcome Reception
07:00:00 Breakfast Sunrise Session: Interactive Case Discussion with the Experts
08:00:00 Welcome and Introductions Joyce O'Shaughnessy
08:05:00 Best of Breast Cancer Science: Metastasis and Breast Cancer Self Seeding Larry Norton
08:35:00 Targeting Metastases Andrea L Richardson, Joyce O'Shaughnessy, Shyamala Maheswaran, Rowan Chlebowski, Jo Anne Zujewski
10:20:00 Break
10:40:00 Optimizing Breast Cancer Local Control Lori J. Pierce, Eleftherios P. Mamounas, Jennifer Bellon, Bruce G Haffty
12:00:00 Panel Discussion
12:20:00 Clinical Dilemma: Is Postmastectomy Radiation the Standard of Care for Patients With 1-3 Positive Nodes? Bruce G Haffty
12:50:00 Postsession Survey
13:00:00 Panel Discussion
16:00:00 Workshop: Novel Molecular Diagnostics with Evolving Clinical Utility (Non-CME Activity) Michael P. Bates, Holly Gallion, Shelly Gunn, Alessandro Cesano, Joseph A. Sparano
17:40:00 Adjourn
Thursday, July 23, 2009
06:30:00 Ask the Faculty Oncology Consultations Breakfast
07:30:00 Presession Survey
07:35:00 Triple-Negative Breast Cancer Andrea L Richardson, Joyce O'Shaughnessy, Lori J. Goldstein, Sofia Merajver, Sandra M. Swain
09:15:00 Panel Discussion
09:35:00 Break
09:55:00 HER2-Driven Breast Cancer Joyce O'Shaughnessy, Edith A Perez, Carlos Arteaga
11:15:00 Panel Discussion
11:35:00 Clinical Dilemma: Is Endocrine Therapy of Benefit in HER2-Driven Breast Cancer? Rachel Schiff
12:05:00 Postsession Survey
12:15:00 Adjourn
16:00:00 Workshop: Novel Therapeutic Targets for Breast Cancer (Non-CME Activity) Joyce Steinberg, Pamela M. Klein, Matthew L. Sherman, Peter Ordentlich, Vincent L. Giranda
18:00:00 Adjourn
Friday, July 24, 2009
06:15:00 Meet the Professors Breakfast
07:00:00 Presession Survey
07:05:00 Updates From St. Gallen 2009 Kathy Albain
07:35:00 Hormone-Responsive Breast Cancer Douglas none Yee, Stephen E. Jones, Suzanne AW Fuqua, Cynthia Ma, James M. Rae, Anne Moore, Joyce O'Shaughnessy
09:35:00 New Insights into Adjuvant Chemotherapy Joyce O'Shaughnessy
09:55:00 Panel Discussion
10:10:00 Break
10:15:00 Novel Insights From Preoperative Therapy Studies Eleftherios P. Mamounas, Angela DeMichele, Louis Chow
11:10:00 Panel Discussion
11:25:00 Clinical Dilemma: Can We Omit Adjuvant Chemotherapy for Some Patients With Hormone Receptor– and Node-Positive Disease? Joseph A. Sparano
11:45:00 Panel Discussion
12:05:00 Postsession Survey
12:15:00 Adjourn
Saturday, July 25, 2009
06:15:00 Meet the Professors Breakfast
07:00:00 Therapeutic Vaccines for Breast Cancer: Are We Making Progress? Leisha Emens
07:05:00 Toward Personalized Breast Cancer Therapies Frankie Ann Holmes
07:20:00 Do Multigene Assays Have Clinical Utility in Patients With Node-Positive Disease? Kathy Albain
07:40:00 Deciphering the Dominant Signaling Pathways: The Power of Proteomics Virginia “Ginny” Espina
08:00:00 Plasticity of the Estrogen Receptor Rachel Schiff
08:20:00 Network Mapping and Individualized MBC Therapy John J. Nemunaitis
08:20:00 Do Viruses Cause Breast Cancer? David M. Euhus
09:00:00 Panel Discussion
09:20:00 Break
09:40:00 Novel Insights Into and New Therapeutic Approaches to Brain Metastases Jo Anne Zujewski
10:00:00 Update on the Treatment of Breast Cancer in Men David M. Euhus
10:20:00 Insights Into Evolving Breast Cancer Practice Patterns in China Louis Chow
10:30:00 Panel Discussion
10:40:00 Insights Into Evolving Breast Cancer Practice Patterns in Peru Henry L. Gomez
10:45:00 Clinical Debate: Estrogen Receptor–Positive Breast Cancer Requires Lifelong Endocrine Therapy Debu Tripathy
11:00:00 Point Frankie Ann Holmes
11:15:00 Counterpoint Debu Tripathy
11:55:00 Closing Comments
12:00:00 Adjourn
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.